Cited 37 times in

37 0

Immunogenicity and Safety of a 9-Valent HPV Vaccine

Authors
 Pierre Van Damme ; Sven Eric Olsson ; Alain Luxembourg ; Scott Vuocolo ; Xiao Sun ; Erin Moeller ; Roger Maansson ; Susan Christiano ; Joshua Chen ; Punnee Pitisuttithum ; Dong Soo Kim ; Li-Min Huang ; Teobaldo Herrera ; Glenda E. Gray ; Xavier Castellsague ; Stanley Block 
Citation
 Pediatrics, Vol.136(1) : e28~e39, 2015 
Journal Title
 Pediatrics 
ISSN
 0031-4005 
Issue Date
2015
Abstract
OBJECTIVES: Prophylactic vaccination of youngwomen aged 16 to 26 years with the 9-valent (6/11/16/18/31/33/45/52/58) human papillomavirus (HPV) virus-like particle (9vHPV) vaccine prevents infection and disease. We conducted a noninferiority immunogenicity study to bridge the findings in young women to girls and boys aged 9 to 15 years. METHODS: Subjects (N = 3066) received a 3-dose regimen of 9vHPV vaccine administered at day 1, month 2, and month 6. Anti-HPV serologic assays were performed at day 1 and month 7. Noninferiority required that the lower bound of 2-sided 95% confidence intervals of geometric mean titer ratios (boys:young women or girls:young women) be >0.67 for each HPV type. Systemic and injection-site adverse experiences (AEs) and serious AEs were monitored. RESULTS: At 4 weeks after dose 3, >99% of girls, boys, and young women seroconverted for each vaccine HPV type. Increases in geometric mean titers to HPV types 6/11/16/18/31/33/45/52/58 were elicited in all vaccine groups. Responses in girls and boys were noninferior to those of young women. Persistence of anti-HPV responses was demonstrated through 2.5 years after dose 3. Administration of the 9vHPV vaccine was generally well tolerated. A lower proportion of girls (81.9%) and boys (72.8%) than young women (85.4%) reported injection-site AEs, most of which were mild to moderate in intensity. CONCLUSIONS: These data support bridging the efficacy findings with 9vHPV vaccine in young women 16 to 26 years of age to girls and boys 9 to 15 years of age and implementing gender-neutral HPV vaccination programs in preadolescents and adolescents.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/140551
DOI
10.1542/peds.2014-3745
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Pediatrics
Yonsei Authors
사서에게 알리기
  feedback
Link
 http://pediatrics.aappublications.org/content/136/1/e28.long
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse